Literature DB >> 23579589

Tissue-type plasminogen activator for stroke mimics: continuing to be swift rather than delaying treatment to be sure.

Waldo R Guerrero, Sean I Savitz.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23579589      PMCID： PMC4218775          DOI： 10.1161/STROKEAHA.113.000927

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  10 in total

1.  Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients.

Authors:  Jeffrey L Saver; William G Barsan
Journal:  Neurology       Date:  2010-03-24       Impact factor: 9.910

2.  Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia.

Authors:  O Y Chernyshev; S Martin-Schild; K C Albright; A Barreto; V Misra; I Acosta; J C Grotta; S I Savitz
Journal:  Neurology       Date:  2010-03-24       Impact factor: 9.910

3.  Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series.

Authors:  Georgios Tsivgoulis; Andrei V Alexandrov; Jason Chang; Vijay K Sharma; Steven L Hoover; Annabelle Y Lao; Wei Liu; Elefterios Stamboulis; Anne W Alexandrov; Marc D Malkoff; James L Frey
Journal:  Stroke       Date:  2011-04-14       Impact factor: 7.914

4.  Safety of thrombolysis in stroke mimics: results from a multicenter cohort study.

Authors:  Sanne M Zinkstok; Stefan T Engelter; Henrik Gensicke; Philippe A Lyrer; Peter A Ringleb; Ville Artto; Jukka Putaala; Elena Haapaniemi; Turgut Tatlisumak; Yaohua Chen; Didier Leys; Hakan Sarikaya; P Michel; Céline Odier; Jörg Berrouschot; Marcel Arnold; Mirjam R Heldner; Andrea Zini; Valentina Fioravanti; Visnja Padjen; Ljiljana Beslac-Bumbasirevic; Alessandro Pezzini; Yvo B Roos; Paul J Nederkoorn
Journal:  Stroke       Date:  2013-02-26       Impact factor: 7.914

5.  Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate.

Authors:  H Ellekjaer; J Holmen; B Indredavik; A Terent
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

6.  Distinguishing between stroke and mimic at the bedside: the brain attack study.

Authors:  Peter J Hand; Joseph Kwan; Richard I Lindley; Martin S Dennis; Joanna M Wardlaw
Journal:  Stroke       Date:  2006-02-16       Impact factor: 7.914

7.  Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990.

Authors:  C S Anderson; K D Jamrozik; P W Burvill; T M Chakera; G A Johnson; E G Stewart-Wynne
Journal:  Med J Aust       Date:  1993-01-18       Impact factor: 7.738

8.  Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.

Authors:  Phillip A Scott; Robert Silbergleit
Journal:  Ann Emerg Med       Date:  2003-11       Impact factor: 5.721

9.  Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome.

Authors:  David T Winkler; Felix Fluri; Peter Fuhr; Stephan G Wetzel; Philippe A Lyrer; Stephan Ruegg; Stefan T Engelter
Journal:  Stroke       Date:  2009-01-22       Impact factor: 7.914

10.  Conditions that mimic stroke in the emergency department. Implications for acute stroke trials.

Authors:  R B Libman; E Wirkowski; J Alvir; T H Rao
Journal:  Arch Neurol       Date:  1995-11
  10 in total
  4 in total

1.  Tissue Plasminogen Activator Prescription and Administration Errors within a Regional Stroke System.

Authors:  Lee S Chung; Aleksander Tkach; Erin M Lingenfelter; Sarah B Dehoney; Jeannie Rollo; Adam de Havenon; L Dana DeWitt; Matthew R Grantz; Haimei Wang; Jana J Wold; Peter M Hannon; Natalie R Weathered; Jennifer J Majersik
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-12-11       Impact factor: 2.136

Review 2.  Stroke Chameleons and Stroke Mimics in the Emergency Department.

Authors:  Ava L Liberman; Shyam Prabhakaran
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

3.  A qualitative description of telemedicine for acute stroke care in Norway: technology is not the issue.

Authors:  Tove Sørensen; Kari Dyb; Ellen Rygh; Rolf Salvesen; Lars Thomassen
Journal:  BMC Health Serv Res       Date:  2014-12-19       Impact factor: 2.655

Review 4.  Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke.

Authors:  Sherita N Chapman; Prachi Mehndiratta; Michelle C Johansen; Timothy L McMurry; Karen C Johnston; Andrew M Southerland
Journal:  Vasc Health Risk Manag       Date:  2014-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.